Halozyme Therapeutics reported $1.49B in Loan Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US USD 1.06M 0
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Amgen AMGN:US USD 37.16B 1.46B
Aptinyx Inc APTX:US USD 24.71M 211K
Baxter International BAX:US USD 16.15B 125M
Cytokinetics CYTK:US USD 609.73M 411.31M
Eli Lilly And LLY:US USD 14.14B 548.2M
Esperion Therapeutics ESPR:US USD 259.49M 407K
Halozyme Therapeutics HALO:US USD 1.49B 344.03M
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
IONIS PHARMACEUT IONS:US USD 1.25B 1.1M
JAZZ PHA JAZZ:US USD 5.7B 294.18M
Mannkind MNKD:US USD 367.5M 509K
Peregrine Pharmaceuticals PPHM:US USD 141.93M 128K
United Therapeutics UTHR:US USD 800M 0